DXCM
DexCom, Inc. · Healthcare
Executive Chair Kevin R Sayer sold $2.0M of DexCom, Inc.
Sold$2,041,999
$76.32Price
26,756Shares
−8%Stake
What DXCM did after the filing
- The stock from Wed, Jul 22 open, $75.04
- +19.5%
- S&P 500, same days
- +3.6%
Measured over 30 trading days, to the Sep 3 close.
Traded Mon, Jul 20. Filed Tue, Jul 21, 4:58 PM ET, after the close. Returns use the Jul 22 open and the Sep 3 close. Not investment advice.